The Endotracheal Tube Market is estimated to be valued at US$ 920.0 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
An endotracheal tube (ET tube) is a thin, flexible tube inserted into the mouth, throat, windpipe, and lungs for administering anaesthesia or ventilation during surgery or during a medical emergency to sustain breathing. They are majorly used in intensive care units (ICUs)to connect a patient's lungs with a ventilator during mechanical ventilation to oxygenate blood and remove carbon dioxide. Growing prevalence of respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD), and respiratory infections has fueled the demand for ventilators, thereby boosting the endotracheal tubes market.
Market Dynamics:
Rising geriatric population susceptible to respiratory diseases is a key driver fueling growth of the endotracheal tube market. As per the UN data, geriatric population aged 65 years and above is projected to reach 1.5 billion in 2050 from 703 million in 2019. Moreover, increasing cases of pre-term births leading to neonatal respiratory distress syndrome (RDS) also necessitates use of endotracheal tubes in pediatric practice. However, high risk of ventilation-associated pneumonia with long term usage of endotracheal tubes and availability of alternative airway management devices like tracheostomy tubes may restrain market growth.
